Notice of Intent to Sole Source – Life Technologies Corp.

The National Institutes of Health (NIH) intends to award a fixed-price purchase order to Life Technologies Corporation for the provision of reagents and consumables needed to run Life Technologies instruments at the Department of Laboratory Medicine (DLM) at the NIH Clinical Center (CC). The acquisition is being conducted using policies unique to the Federal Acquisition Regulation (FAR) Part 13 – Simplified Acquisition Procedures. • The products to be purchased include reagents and consumables for Life Technologies instruments. • The place of performance is Bethesda, MD 20892 USA. • The NIH has determined that Life Technologies Corporation is the sole-source manufacturer and supplier of the required consumables and kits. • The department has validated these reagents for use in specific assays and switching to another system would entail lengthy validations and potential delays in patient care.